Clinical trial
TITRE III: TIV Infant/Toddler Response Evaluation - Influenza B Immunogenicity Investigation
NCT03753347 is registered in ClinicalTrials.gov with British Columbia Centre for Disease Control as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TITRE III: TIV Infant/Toddler Response Evaluation - Influenza B Immunogenicity Investigation
- Lead sponsor
- British Columbia Centre for Disease Control
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- December 1, 2018
- Completion date
- June 30, 2025
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza